ISSN: 0004-069X
Journal Home
Journal Guideline
Archivum Immunologiae et Therapiae Experimentalis Q1 Unclaimed
Archivum Immunologiae et Therapiae Experimentalis is a journal indexed in SJR in Medicine (miscellaneous) and Immunology with an H index of 76. It has a price of 3060 €. It has an SJR impact factor of 1,026 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,026.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


3060 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,026
SJR Impact factor76
H Index24
Total Docs (Last Year)84
Total Docs (3 years)1752
Total Refs299
Total Cites (3 years)81
Citable Docs (3 years)3.75
Cites/Doc (2 years)73.0
Ref/DocOther journals with similar parameters
MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1
Compare this journals
Aims and Scope
Best articles by citations
Current advances in the management of urticaria
View moreMesenchymal stromal cells: tissue engineers and immune response modulators
View moreBronchial hyper-responsiveness, subepithelial fibrosis, and transforming growth factor-beta1 expression in patients with long-standing and recently diagnosed asthma
View moreErratum to: Neutrophil Myeloperoxidase: Soldier and Statesman
View moreClinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse
View morePolymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients
View moreModifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis
View moreMicrobiological Findings and Treatment of EBV-Associated Hemophagocytic Lymphohistiocytosis: A Case Report
View moreSerum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness
View moreComplement: coming full circle
View moreAcetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?
View moreEffects of IFN-beta1a and IFN-beta1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis
View moreAnti-CCL25 Antibody Prolongs Skin Allograft Survival by Blocking CCR9 Expression and Impairing Splenic T-Cell Function
View moreFamilial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome
View moreDo Langerhans cells play a role in vulvar epithelium resistance to squamous cell carcinoma?
View moreModulatory Effects of Oral Bovine Lactoferrin on the IgA Response at Inductor and Effector Sites of Distal Small Intestine from BALB/c Mice
View moreGlucose transport in human peripheral blood lymphocytes influenced by type 2 diabetes mellitus
View moreThe role of the lysophospholipid sphingosine 1-phosphate in immune cell biology
View morePositive and negative regulatory mechanisms in high-affinity IgE receptor-mediated mast cell activation
View moreA reflection on open-access, citation counts, and the future of scientific publishing
View moreStructural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication
View moreHuman Mast Cells and Mastocytosis: Harnessing MicroRNA Expression as a New Approach to Therapy?
View moreResponse of Specific Immunoglobulin E to Foods in Children with Atopic Dermatitis
View moreNegative signals from FceRI engagement attenuate mast cell functions
View more
Comments